Partnership Deal

Advanced Medical Solutions Grp PLC
12 February 2003


For Immediate Release:                         07:00 Wednesday 12 February 2003



          Advanced Medical Solutions Group plc ('AMS' or the Company)

                   Announces Partnership Deal with PDI, Inc.

              PDI to market and distribute AMS products across US


Winsford, UK: AMS, the global woundcare technology company, today announced that
it had entered into agreements with the Medical Devices and Diagnostics Division
of New Jersey-based PDI, Inc. (PDI MDD) for marketing and distribution of a
range of AMS  products into the $5 billion US woundcare market.

PDI MDD recently formed a dedicated sales and marketing team focussed on the US
advanced woundcare market.  As part of this new strategy PDI MDD is partnering
with specific technology companies that it feels can provide a pipeline of
innovative products.  PDI MDD's 30 field sales specialists are backed up by PDI
InServe - which comprises of over 1000 medical technologists, nurses, and other
clinical professionals nationwide who provide clinical sales support to ensure
rapid penetration of the hospital and nursing home markets through end-user
education and product knowledge.

The products covered under these agreements include a number of AMS's
proprietary foam-based advanced woundcare dressings and its MedLogic LiquiShield
TM skin protection product, which recently received FDA 510(k) approval for use
on damaged as well as intact skin.

Commenting on this deal, Dr. Don Evans, Chief Executive Officer of AMS stated:

'We believe that a dedicated sales & marketing organisation such as PDI provides
an ideal partner for the successful commercialisation of our technology and will
ensure that our products receive the necessary focus in the US market.'

Lloyd Fishman, Executive Vice President and General Manager of PDI MDD, added:

'I am delighted that we have been able to partner with AMS. Not only can they
immediately provide us with a number of exciting products, but they also have
the technology and R &D capability to deliver a product pipeline going forward
to help us build a strong woundcare business.'


                                    - ENDS -



For further information, please contact:

Advanced Medical Solutions Group plc                  Tel : [phone]
Don Evans, Chief Executive
www.admedsol.com

Buchanan Communications                                Tel: [phone]
Nicola How                                                 Mobile: [phone]
Fergus Mellon



Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the £15 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The recent acquisition of MedLogic has brought AMS products and technology in
cyanoacrylate based tissue adhesives and sealants sold direct to A & E
departments or through distributors.

AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson,
Molnlycke Healthcare, Coloplast, Smith + Nephew and  Beiersdorf.




PDI is an innovative commercial sales and marketing company providing solutions
to the biopharmaceutical and medical devices & diagnostics industries. Its three
business units offer service and product-based capabilities for companies
seeking to maximize profitable brand sales growth.  The three units include the
PDI Pharmaceutical Products Group, the PDI Sales & Marketing Services Group and
the PDI Medical Devices and Diagnostics Group.

For more information, visit the Company's website at www.pdi-inc.com.


                      This information is provided by RNS
            The company news service from the London Stock Exchange